Jarushka Naidoo Highlights 10 Years of Immunotherapy Progress and Trial Lessons

1 articles · Updated · Oncodaily · May 21

Jarushka Naidoo posted on X that Solange Peters presented a decade of progress in immunotherapy alongside practical lessons on building and sustaining clinical trials.
10 years of experience were framed around trial execution needs, including protected time for principal investigators, strong local leadership, adequate trials-unit staffing, and a balance between industry and academic studies.
The post positions trial infrastructure—not just scientific advances—as central to extending immunotherapy progress in oncology.

As immunotherapy trials grow more complex, is our research system becoming the biggest barrier to finding a cure for cancer?

Can artificial intelligence fix the broken economics of drug development and the high failure rate of modern cancer trials?

With thousands of new drugs, how can trials better predict who will benefit versus who will suffer fatal side effects?